Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy.
J Am Coll Cardiol
; 78(11): 1114-1123, 2021 09 14.
Article
in En
| MEDLINE
| ID: mdl-34503680
ABSTRACT
BACKGROUND:
Although statins reduce cardiovascular morbidity and mortality, only about one-half of eligible patients receive treatment. Safe and appropriate consumer access to statins could have a significant positive public health impact.OBJECTIVES:
This study compares the concordance between a participant and clinician assessment of eligibility for statin therapy using a technology-assisted approach.METHODS:
A total of 500 participants, 83 with limited literacy, completed an at-home Web-based application to assess appropriateness for treatment with rosuvastatin 5 mg. The Web application is designed to assess eligibility for a moderate-intensity statin based on current guidelines and deny access to individuals with contraindications to rosuvastatin. Subsequently, participants visited a research site where clinicians, blinded to the information the participant entered, performed an independent Web application assessment. The Web application is programmed for 1 of 3 rosuvastatin treatmentoutcomes:
"OK to use," "not right for you," or "ask a doctor." The primary endpoint was the percent of participants whose self-selected eligibility for nonprescription rosuvastatin was concordant with clinician assessment.RESULTS:
For the primary endpoint, participant selection for statin therapy was concordant with clinician selection in 481 (96.2%) of 500 participants (95% confidence interval 94.1%-97.7%), of whom 23 (4.6%) were deemed appropriate and 458 (91.6%) were deemed inappropriate for treatment. Discordance was due to incorrect self-selection ("OK to use") in 3 cases, incorrect rejection ("not right for you") in 14 cases and an incorrect "ask a doctor" outcome in 2 cases.CONCLUSIONS:
The use of a technology-assisted approach to consumer self-selection for statin therapy resulted in participant self-selection that showed substantial agreement with clinician selection.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Self Medication
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Nonprescription Drugs
/
Rosuvastatin Calcium
Type of study:
Guideline
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Am Coll Cardiol
Year:
2021
Document type:
Article